NCT00435929View on ClinicalTrials.gov

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
HIV Infections
Interventions
DRUG

Ritonavir

100mg po bid

DRUG

saquinavir [Invirase]

1000mg po bid

Trial Locations (8)

19104

Philadelphia

60612

Chicago

75204

Dallas

08244

Somers Point

08043

Voorhees Township

K1H 8L6

Ottawa

M5G 2C4

Toronto

00927

San Juan

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00435929 - A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection. | Biotech Hunter | Biotech Hunter